Sign inJoin waitlistJoin the waitlist

AR

Alexander Rotenberg

Director of Neuromodulation · Beth Israel Deaconess Medical Center

Credentials: · · · · ·

History

Neuromodulation · Beth Israel Deaconess Medical Center
Present

Clinical Neurophysiology
2005–2006
Child Neurology
Boston Children's Hospital
2000–2005
SUNY Downstate University Health Sciences University College of Medicine
1996–2000

Research

Safety and recommendations for TMS use in healthy subjects and patient populations, with updates on training, ethical and regulatory issues: Expert Guidelines
Review · Clinical Neurophysiology · 2021 · 1,135 citations
Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016
Review · Brain stimulation · 2016 · 1,035 citations
Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions
Review · Brain stimulation · 2012 · 1,028 citations

AP
Alvaro Pascual-Leone
58 papers
PP
Phillip Pearl
22 papers
Tobias Loddenkemper
22 papers · 1 as a fellow
Annapurna Poduri
16 papers
MT
Masanori Takeoka
14 papers
MT
Melissa Tsuboyama
14 papers
MS
Mustafa Sahin
14 papers
Sanjeev Kothare
14 papers
Jurriaan Peters
13 papers · 11 as a resident
Frances Jensen
11 papers
JM
Joseph Madsen
10 papers
UD
Ugur Damar
10 papers · 6 as a resident

Grants

Developing Brain Penetrable AAV Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
National Institute of Neurological Disorders and Stroke · R41
Contact PI · $500K · Galibra Neuroscience, Inc.
2025–2027
Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
National Institute of Neurological Disorders and Stroke · R33
Contact PI · $342.7K · Boston Children's Hospital
2024–2027
Mitigating Post-Traumatic Epileptogenesis by Enhancing Synaptic Glutamate Transport via Long-Term Non-Bactericidal Beta-Lactam Administration
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $486.8K · Boston Children's Hospital
2024–2027
Gene Therapy for Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
National Institute of Neurological Disorders and Stroke · R61
Contact PI · $701.7K · Boston Children's Hospital
2024–2026

Clinical trials

CBD Delivery with the A-Synaptic GT4 Transdermal Delivery System in with Dravet Syndrome And/or Lennox-Gastaut Syndrome
Principal investigator · Not yet recruiting · Phase 1, Phase 2
Alexander Rotenberg
2025–2027
Transcranial Magnetic Stimulation to Measure Cortical Excitability in Dravet Syndrome
Principal investigator · Unknown
Boston Children's Hospital
2020–2022
Effects of Green Light Exposure on Epileptic Spikes in Patients With Refractory Epilepsy
Principal investigator · Unknown
Boston Children's Hospital
2019–2023
Investigation of Brain Plasticity in Autism Spectrum Disorders
Principal investigator · Unknown
Boston Children's Hospital
2019–2022